| Sabine County Hospital | |
| Po Box 750, 2301 Hwy 83 W, Hemphill, Texas 75948 | |
| (409) 787-3300 | |
| Not Available |
| Name | Sabine County Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | Po Box 750, 2301 Hwy 83 W, Hemphill, Texas |
| Ownership | Proprietary |
| Emergency Services | Yes |
| Medicare ID (CCN) | 451361 |
| NPI Number | 1932379856 |
| Organization Name | PREFERRED HOSPITAL LEASING HEMPHILL, INC |
| Doing Business As | SABINE COUNTY HOSPITAL |
| Address | 2301 Hwy 83 West, Hemphill, TX 75948 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 409-787-3300 |
News Archive
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
In a small study of opioid prescriptions filled at a Johns Hopkins Medicine outpatient pharmacy, researchers found that handwritten orders for the drugs contribute heavily to a trio of prescribing and processing errors in contrast to those created electronically.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, announced the initiation of a phase 2 study of dalantercept, a novel angiogenesis inhibitor that targets the activin receptor-like kinase 1 (ALK1) pathway.
N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD).
› Verified 2 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
People with psychosis often develop an addiction disorder: almost one in two patients with schizophrenia are affected once during their lifetime. Patients with a dual diagnosis mostly have a poorer prognosis, and their disorder often becomes chronic.
In a small study of opioid prescriptions filled at a Johns Hopkins Medicine outpatient pharmacy, researchers found that handwritten orders for the drugs contribute heavily to a trio of prescribing and processing errors in contrast to those created electronically.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, announced the initiation of a phase 2 study of dalantercept, a novel angiogenesis inhibitor that targets the activin receptor-like kinase 1 (ALK1) pathway.
N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD).
› Verified 2 days ago
Sabine County Hospital Critical Access Hospital Location: Po Box 750, 2301 Hwy 83 W, Hemphill, Texas 75948 Phone: (409) 787-3300 |